Breast cancers associated with BRCA1/2 mutations have a deficiency in homologous recombination repair, a mechanism of DNA double-strand breaks repair, the defect of which is synergistically lethal with the inhibition of single-strand DNA repair [73]. The gene discussed is BRCA1; the disease is breast cancer.